Pretreatment neutrophil-to-lymphocyte ratio as predictor of survival for patients with metastatic nasopharyngeal carcinoma

被引：59
|
作者：
Jin, Ying [1 ]
Ye, Xiao [2 ]
He, Chunxiao [1 ]
Zhang, Beibei [1 ]
Zhang, Yiping [1 ]
机构：
[1] Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou 310022, Zhejiang, Peoples R China
[2] Zhejiang Prov Peoples Hosp, Dept Endocrinol, Hangzhou, Zhejiang, Peoples R China
来源：
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2015年 / 37卷 / 01期
关键词：
lymphocyte; metastatic nasopharyngeal carcinoma; neutrophil; neutrophil lymphocyte ratio; overall survival; PROGNOSTIC-FACTORS; UNDIFFERENTIATED CARCINOMA; PERIPHERAL NEUTROPHILS; DISTANT METASTASIS; POOR-PROGNOSIS; CANCER; EPIDEMIOLOGY; INFLAMMATION; TRAFFICKING; APOPTOSIS;
D O I：
10.1002/hed.23565
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
BackgroundThe outcomes of patients with metastatic nasopharyngeal carcinoma (NPC) differ between individuals. The purpose of this study was to examine the impact of neutrophil-to-lymphocyte ratio (NLR) on survival in patients with metastatic NPC. MethodsA total of 229 patients with disseminated NPC were evaluated. The effects of pretreatment peripheral blood neutrophil, lymphocyte, and NLR on survival were examined using the proportional hazards regression model to estimate hazard ratio (HR). The relationship between short-term treatment efficacy and pretreatment NLR was analyzed using the chi-square test. ResultsThe pretreatment elevated neutrophil count (p=.020), percentage of neutrophil (p < .001), and NLR (p=.002) were statistically significantly associated with a poor prognosis. The cutoff value selected for NLR was 3.6. The median survival time was 15.3 months for the high-NLR group and was 23.5 months for the low-NLR group (p < .001). ConclusionNLR is a prognosticator in patients with metastatic NPC. (c) 2014 Wiley Periodicals, Inc. Head Neck37: 69-75, 2015
引用
收藏
页码：69 / 75
页数：7
相关论文
共 50 条
  • [1] Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study
    Taguchi, Satoru
    Nakagawa, Tohru
    Matsumoto, Akihiko
    Nagase, Yasushi
    Kawai, Taketo
    Tanaka, Yoshinori
    Yoshida, Kanae
    Yamamoto, Sachi
    Enomoto, Yutaka
    Nose, Yorito
    Sato, Toshikazu
    Ishikawa, Akira
    Uemura, Yukari
    Fujimura, Tetsuya
    Fukuhara, Hiroshi
    Kume, Haruki
    Homma, Yukio
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (07) : 638 - 643
  • [2] The trend of neutrophil-to-lymphocyte ratio as a predictor of prognosis to nasopharyngeal carcinoma
    Yang, P.
    Zhao, Y.
    Mohamed, A.
    Liang, H.
    Chen, C.
    Xu, Y.
    Nantavithya, C.
    Kannarunimit, D.
    Shi, Y.
    Wang, H.
    Jin, H.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S368 - S368
  • [3] PRETREATMENT NEUTROPHIL-TO-LYMPHOCYTE RATIO IS AN INDEPENDENT PREDICTOR OF METASTASIS IN PATIENTS WITH NON-METASTATIC RENAL CELL CARCINOMA
    Ohno, Y.
    Nakashima, J.
    Tanaka, A.
    Ohori, M.
    Hatano, T.
    Tachibana, M. O.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 117 - 117
  • [4] Predictive value of pretreatment neutrophil-to-lymphocyte ratio in survival of patients with hepatocellular carcinoma
    Hong, Young Mi
    Cho, Mong
    Yoon, Ki Tae
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E838 - E838
  • [5] Editorial Comment to Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study
    Mitsui, Yozo
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (07) : 643 - 644
  • [6] Cutoff point of neutrophil-to-lymphocyte ratio for predicting survival in nasopharyngeal carcinoma
    Setakornnukul, Jiraporn
    Chanvimalueng, Waipoj
    Patumanond, Jayanton
    Thephamongkhol, Kullathorn
    [J]. MEDICINE, 2021, 100 (34) : E27095
  • [7] Neutrophil-to-lymphocyte ratio trend: A novel prognostic predictor in patients with nasopharyngeal carcinoma receiving radiotherapy
    Yang, Pei
    Zhao, Yu
    Liang, Hao
    Zhou, Guanzhi
    Youssef, Bassem
    Elhalawani, Hesham
    Li, Meizhen
    Tan, Fengbo
    Jin, Yi
    Jin, Hekun
    Zhu, Hong
    Mohamed, Abdallah Sherif Radwan
    Chonnipa, Nantavithya
    Kannarunimit, Danita
    Shi, Yingrui
    Wang, Hui
    Fuller, Clifton David
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2022, 37 (03): : 270 - 279
  • [8] Pretreatment Neutrophil-to-Lymphocyte Ratio as an Independent Predictor of Recurrence in Patients With Nonmetastatic Renal Cell Carcinoma
    Ohno, Yoshio
    Nakashima, Jun
    Ohori, Makoto
    Hatano, Tadashi
    Tachibana, Masaaki
    [J]. JOURNAL OF UROLOGY, 2010, 184 (03): : 873 - 878
  • [9] Pretreatment Neutrophil-Lymphocyte Ratio An Independent Predictor of Survival in Patients With Hepatocellular Carcinoma
    Gao, Fangyuan
    Li, Xiaoshu
    Geng, Mingfan
    Ye, Xieqiong
    Liu, Huimin
    Liu, Yao
    Wan, Gang
    Wang, Xianbo
    [J]. MEDICINE, 2015, 94 (11)
  • [10] Pretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancer
    Wang, Xin
    Teng, Feifei
    Kong, Li
    Yu, Jinming
    [J]. ONCOTARGETS AND THERAPY, 2016, 9 : 5761 - 5770
12345